» Articles » PMID: 32511274

Anti-correlation of HER2 and Focal Adhesion Complexes in the Plasma Membrane

Overview
Journal PLoS One
Date 2020 Jun 9
PMID 32511274
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Excess presence of the human epidermal growth factor receptor 2 (HER2) as well as of the focal adhesion protein complexes are associated with increased proliferation, migratory, and invasive behavior of cancer cells. A cross-regulation between HER2 and integrin signaling pathways has been found, but the exact mechanism remains elusive. Here, we investigated whether HER2 colocalizes with focal adhesion complexes on breast cancer cells overexpressing HER2. For this purpose, vinculin or talin green fluorescent protein (GFP) fusion proteins, both key constituents of focal adhesions, were expressed in breast cancer cells. HER2 was either extracellularly or intracellularly labeled with fluorescent quantum dots nanoparticles (QDs). The cell-substrate interface was analyzed at the location of the focal adhesions by means of total internal reflection fluorescent microscopy or correlative fluorescence- and scanning transmission electron microscopy. Expression of HER2 at the cell-substrate interface was only observed upon intracellular labeling, and was heterogeneous with both HER2-enriched and -low regions. In contrast to an expected enrichment of HER2 at focal adhesions, an anti-correlated expression pattern was observed for talin and HER2. Our findings suggest a spatial anti-correlation between HER2 and focal adhesion complexes for adherent cells.

Citing Articles

Oleanolic Acid's Semisynthetic Derivatives HIMOXOL and Br-HIMOLID Show Proautophagic Potential and Inhibit Migration of HER2-Positive Breast Cancer Cells In Vitro.

Lisiak N, Lewicka I, Kaczmarek M, Kujawski J, Bednarczyk-Cwynar B, Zaprutko L Int J Mol Sci. 2021; 22(20).

PMID: 34681931 PMC: 8538366. DOI: 10.3390/ijms222011273.


EGFR Expression in HER2-Driven Breast Cancer Cells.

Weinberg F, Peckys D, de Jonge N Int J Mol Sci. 2020; 21(23).

PMID: 33260837 PMC: 7729501. DOI: 10.3390/ijms21239008.

References
1.
Peckys D, Korf U, de Jonge N . Local variations of HER2 dimerization in breast cancer cells discovered by correlative fluorescence and liquid electron microscopy. Sci Adv. 2015; 1(6):e1500165. PMC: 4646781. DOI: 10.1126/sciadv.1500165. View

2.
Slamon D, Clark G, Wong S, Levin W, Ullrich A, McGuire W . Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987; 235(4785):177-82. DOI: 10.1126/science.3798106. View

3.
Falcioni R, Antonini A, Nistico P, Di Stefano S, Crescenzi M, Natali P . Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell lines. Exp Cell Res. 1997; 236(1):76-85. DOI: 10.1006/excr.1997.3695. View

4.
Burridge K, Guilluy C . Focal adhesions, stress fibers and mechanical tension. Exp Cell Res. 2015; 343(1):14-20. PMC: 4891215. DOI: 10.1016/j.yexcr.2015.10.029. View

5.
Jeong J, Kim W, Kim L, VanHouten J, Wysolmerski J . HER2 signaling regulates HER2 localization and membrane retention. PLoS One. 2017; 12(4):e0174849. PMC: 5378417. DOI: 10.1371/journal.pone.0174849. View